Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Can B Corp CANB

Can B Corp. is a health and wellness company. It is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. It develops its own line of proprietary products, as well seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. Its products are sold to consumers online, via retailers, marketing partners, and events through doctors and health and wellness organizations.


OTCQB:CANB - Post by User

<< Previous
Bullboard Posts
Next >>
Post by AveragePennyon Sep 27, 2021 11:24am
61 Views
Post# 33923922

Can B Corp. Discusses Significant Delta-8 and Isomer

Can B Corp. Discusses Significant Delta-8 and Isomer

Jolly began the interview by asking about the Company's latest projects. "We have a manufacturing division, hemp division, and medical device division," explained Alfonsi. "Let's start with our Pure Health products," said Alfonsi. "We have doubled our capacity," he shared. "We are getting NSF certified, which will give us the ability to do pharmaceutical goods," said Alfonsi. He also shared that the Company's Canbiola brand is now available in hundreds of doctor's offices.

Alfonsi then elaborated on the progress of the Company's medical device division. "We moved into Michigan and we are now in approximately 25 physician offices," said Alfonsi. "By opening up Michigan, we are exceeding our revenue model there."

"However, the exciting part of our business that we are getting into is the hemp division," continued Alfonsi, before elaborating on the Company's purchase of Colorado facility assets. "Our capacity has grown dramatically," said Alfonsi. "We're able to do around 3,000 liters per month of [Delta-8 and other isomers]," he explained. "We were able to bring in a whole new section of business for us because now we are able to make our own isolate."

"What do you think the future of the hemp industry looks like over the next two to three quarters?" asked Jolly. "For my company, we are in a boom right now," said Alfonsi. "We have control of 100% of our supply chain," he added. "By creating isomers with Delta-8, which is very hot on the street right now, we are able to create profit," said Alfonsi, before elaborating on the potential of isomers.

"With all of these acquisitions, what do you expect for the Company over the next 12 months?" asked Jolly. Alfonsi then discussed the significant revenue potential of the Company's hemp division, paired with the potential of their additional divisions.

"Do you feel that your market cap is very undervalued?" asked Jolly. "Yes," said Alfonsi. "If you liquidated all of my assets today, you would have about $12 million in hard assets and we have 22 million shares issued," he explained. "Honestly, in my opinion the valuation should be twice the market cap that it is now."

https://www.newsfilecorp.com/release/97728

<< Previous
Bullboard Posts
Next >>